Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
FRA:UNJ's Price-to-Median-PS-Value is ranked worse than 67.83% of 544
companies
in the Drug Manufacturers industry
Industry Median: 0.9
vs FRA:UNJ: 1.12
United Laboratories International Holdings (FRA:UNJ) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
United Laboratories International Holdings's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
1.00
/
0.89
=
1.12
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Laboratories International Holdings Median PS Value Related Terms
United Laboratories International Holdings Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Laboratories International Holdings Median PS Value Chart
United Laboratories International Holdings Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
United Laboratories International Holdings Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where United Laboratories International Holdings's Price-to-Median-PS-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Laboratories International Holdings (FRA:UNJ) has a Median PS Value of €0.89 as of Jul. 16, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on United Laboratories International Holdings and its competitors. This is near median its historical median of 0.96. Over the past decade, United Laboratories International Holdings' Median PS Value has ranged from 0.70 to 1.53. According to the industry distribution chart, United Laboratories International Holdings ranks #369 out of 544 companies in the Drug Manufacturers industry, placing it in the top 67.8%.
Is United Laboratories International Holdings' Median PS Value too high?
United Laboratories International Holdings' current Median PS Value of €0.89 is near median its 10-year median of 0.96. Over the past 10 years, this metric has ranged from a low of 0.70 to a high of 1.53. Based on the distribution chart, United Laboratories International Holdings ranks #369 out of 544 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, United Laboratories International Holdings has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does United Laboratories International Holdings' Median PS Value compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, United Laboratories International Holdings ranks #369 out of 544 companies for Median PS Value. This places United Laboratories International Holdings in the lower half of its industry. The industry median Median PS Value is 0.90. Historically, United Laboratories International Holdings' own Median PS Value has ranged from 0.70 to 1.53 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.90, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on United Laboratories International Holdings and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. United Laboratories International Holdings's current Median PS Value is €0.89, which is near median its own 10-year median of 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Laboratories International Holdings stock overvalued right now?
United Laboratories International Holdings (FRA:UNJ) has a current Median PS Value of €0.89. The stock's GF Value™ is €0.96, compared to a current price of €1.00 — trading 4.2% above its estimated fair value. The current Median PS Value is €0.89, which is near median its 10-year median of 0.96. United Laboratories International Holdings' overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For United Laboratories International Holdings (FRA:UNJ), the current Median PS Value is €0.89 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is United Laboratories International Holdings (FRA:UNJ) Overvalued in 2026?
Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be overvalued.
The current stock price of €1.00 is trading 4.2% above its estimated GF Value™ of €0.96.
Key valuation signals for FRA:UNJ:
Median PS Value: €0.89 (near median its 10-year median of 0.96)
GF Value™: €0.96 vs. price of €1.00 (4.2% above fair value)
No single metric tells the full story. See the FRA:UNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
United Laboratories International Holdings Business Description
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
90GF Score
Get the complete analysis for FRA:UNJ
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:UNJ has been successfully added to your 
